Tech Company Financing Transactions
PQ Bypass Funding Round
PQ Bypass, based in Sunnyvale, secured $60 million from Deerfield Capital, MedTech Venture Partners and Seroba Life Sciences.
Transaction Overview
Company Name
Announced On
1/15/2019
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Funds will be used to advance the clinical development of the company's technology for the treatment of long blockages in leg arteries caused by PAD.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
269 North Mathilda Ave.
Sunnyvale, CA 94086
USA
Sunnyvale, CA 94086
USA
Phone
Website
Email Address
Not Recorded
Overview
PQ Bypass, Inc. is a Silicon Valley-based medical device company working to transform the treatment of long-segment femoropopliteal disease with minimally-invasive endovascular solutions. PQ Bypass is a former Company-In-Residence at the Fogarty Institute for Innovation and is operated by recognized leaders in the medical device industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Ferrari
Vice President
Heather Simonsen
VP - Operations
Bradley Brown
VP - Operations
Scott Hosaka
VP - Product Management
Kumar Jambunathan
VP - Regulatory Affairs
Pharoah Garma
Browse more venture capital transactions:
Prev: 1/15/2019: Trice Medical venture capital transaction
Next: 1/15/2019: Appvance venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs